Peer Reviewed


Document Type


Publication Date



Adolescent, Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Cross-Sectional Studies, Female, HIV Infections, HIV-1, Humans, Infectious Disease Medicine, Ireland, Male, Medical Audit, Middle Aged, Retrospective Studies, Viral Load, Young Adult


The original article is available at


We have assessed the efficacy of anti retroviral therapy (ART) using undetectable viral load (VL) (/ml) as a marker of virological success, in patients who have Human Immunodeficiency Virus (HIV) attending the Department of Infectious Disease. A cross-sectional review of patients' case notes was used to obtain their demographics and treatment details. 79% (253) of the hospital case notes of clinic population was available for analysis, which represents 90% of those receiving ART in the clinic. 166/253 of the cohort were receiving treatment at the time of this study and 95% (157/166) of these were on treatment for greater than 6 months. The total virological success rate is 93%, which is comparable to other centres and are as good as those from published clinical trials. 56% of those on therapy who have virological failure were Intravenous Drug Users (IVDUs). Case by case investigation for those with treatment failure is warranted.


International Public Health | Medicine and Health Sciences


Reyad A, Waldron C, Canning R, O'Shea D, Coakley P, McConkey S. An audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic. Irish Medical Journal. 2009;102(6):186-8.

PubMed ID


Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.